CEVA INC (CEVA)
CEVA INC (CEVA)
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -4,459 | -1,098 | -2,509 | -7,031 |
| Depreciation | 685 | 941 | 947 | 1,548 |
| Realized gain, net on sale of available-for-sale marketable securities | NaN | 40 | 0 | 16 |
| Amortization of intangible assets | 176 | 208 | 208 | 417 |
| Equity-based compensation | 5,372 | 5,698 | 4,873 | 9,225 |
| Accretion of discount on available-for-sale marketable securities | 104 | 120 | 175 | 460 |
| Unrealized foreign exchange (gain) loss | -510 | -94 | -546 | 1,669 |
| Gain on sale of intrinsix | NaN | 0 | NaN | NaN |
| Remeasurement of marketable equity securities | -64 | -4 | -1 | 262 |
| Trade receivables, net | -374 | -378 | 13,172 | -948 |
| Prepaid expenses and other assets | 5,847 | -758 | -2,381 | 2,858 |
| Operating lease right-of-use assets | 296 | -13,524 | 683 | 1,166 |
| Accrued interest on bank deposits | 35 | 31 | -62 | 54 |
| Deferred taxes, net | -3 | 1,154 | 184 | -283 |
| Trade payables | -295 | 110 | -24 | 466 |
| Deferred revenues | -528 | 444 | -160 | -387 |
| Accrued expenses and other payables | -910 | 30 | 473 | -1,393 |
| Accrued payroll and related benefits | -799 | 2,233 | 386 | -4,606 |
| Operating lease liability | 705 | 12,347 | -561 | -1,560 |
| Income taxes payable | NaN | -706 | NaN | NaN |
| Accrued severance pay, net | 41 | -148 | 0 | 64 |
| Net cash used in operating activities | -4,885 | 8,724 | -5,859 | -6,221 |
| Proceeds from the sale of intrinsix, net | NaN | 0 | 0 | 3,470 |
| Business combination | NaN | 0 | NaN | NaN |
| Asset acquisition-Ceva Technologies Single Member Private Company | NaN | 0 | 0 | 0 |
| Proceeds from bank deposits | NaN | 0 | 2,000 | 0 |
| Purchase of property and equipment | 2,315 | 1,493 | 426 | 1,002 |
| Investment in bank deposits | 3,000 | 0 | 2,000 | 705 |
| Proceeds from sale of available-for-sale marketable securities | NaN | 7,387 | 0 | 3,914 |
| Investment in available-for-sale marketable securities | 24,601 | 56,597 | 19,092 | 30,751 |
| Proceeds from maturity of available-for-sale marketable securities | 14,110 | 2,100 | 13,337 | 45,860 |
| Net cash provided by (used in) investing activities | -15,806 | -48,603 | -6,181 | 20,786 |
| Purchase of treasury stock | NaN | 0 | 988 | 6,162 |
| Proceeds from issuance of common stock, net of issuance costs | NaN | 63,261 | NaN | NaN |
| Proceeds from exercise of stock-based awards | 1,551 | 0 | 1,594 | 1,630 |
| Net cash provided by financing activities | 1,551 | 63,261 | 606 | -4,532 |
| Effect of exchange rate changes on cash and cash equivalents | -79 | -66 | -378 | 551 |
| Increase (decrease) in cash and cash equivalents | -19,219 | 23,316 | -11,812 | 10,584 |
| Cash and cash equivalents at the beginning of the year | 40,586 | 17,270 | 18,498 | NaN |
| Cash and cash equivalents at the end of the year | 21,367 | 40,586 | 17,270 | NaN |